tiprankstipranks
pc:ele2u

Elevara Medicines

Therapeutics
Elevara Medicines is a clinical-stage biotech company developing therapies for rheumatoid arthritis and chronic inflammatory diseases. The company's lead program, ELV001, is a first-in-class oral CDK4/6 inhibitor targeting fibroblast-like synoviocytes, aiming to disrupt early line RA treatment by achieving clinical remission in combination with standard care.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$70M
Total Amount Raised$70M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$70M
Latest Funding Amount$70M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 22, 2025
Series A
$70.00M
―

Investors

Investor Name
Funding Round
Forbion
Series A
Sofinnova Partners
Series A
Monograph Capital
Series A

Related News and Analysis

Elevara Advances Lead RA Drug With First Patient Dosed in Global Phase 2b Trial

Elevara Advances Lead RA Drug With First Patient Dosed in Global Phase 2b Trial

New updates have been reported about Elevara Medicines. Elevara Medicines has dosed the first patient in START-SYNERGY, its...
25d ago
ELE2U
Bedrock Data Recognized Among Fast-Growing Midsize Cybersecurity Firms

Bedrock Data Recognized Among Fast-Growing Midsize Cybersecurity Firms

According to a recent LinkedIn post from Bedrock Data, the company has been included in IT-Harvest’s 2026 Cyber...
1d ago
BED6Z
Cornerstone Robotics Showcases Sentire Surgical System at CMEF Shanghai

Cornerstone Robotics Showcases Sentire Surgical System at CMEF Shanghai

A LinkedIn post from Cornerstone Robotics highlights the company’s participation in the 93rd China International Medical Equipment Fair...
1d ago
CORNE
ClickHouse Targets Real-Time AI Data Workloads With Expanded Conference Presence

ClickHouse Targets Real-Time AI Data Workloads With Expanded Conference Presence

According to a recent LinkedIn post from ClickHouse, the company is planning a broad presence at the AI...
1d ago
CLHSE
Cohesity Highlights Cyber Resilience Focus, Nutanix Partnership and Customer Recognition

Cohesity Highlights Cyber Resilience Focus, Nutanix Partnership and Customer Recognition

According to a recent LinkedIn post from Cohesity, the company is emphasizing the limitations of largely manual and...
1d ago
COHSY
Cohesity Positions Data Recovery as Key Risk Mitigation for AI-Driven Security

Cohesity Positions Data Recovery as Key Risk Mitigation for AI-Driven Security

A LinkedIn post from Cohesity highlights the growing security risks tied to agentic artificial intelligence in enterprise environments....
1d ago
COHSY
AdvantageClubai Highlights Filipino Day of Valor and Workplace Culture Focus

AdvantageClubai Highlights Filipino Day of Valor and Workplace Culture Focus

According to a recent LinkedIn post from AdvantageClubai, the company is marking the Philippines’ Araw ng Kagitingan (Day...
1d ago
ADVAN
Flexport Capital Spotlighted as Growth Financing Partner for Portland Leather Goods

Flexport Capital Spotlighted as Growth Financing Partner for Portland Leather Goods

According to a recent LinkedIn post from Flexport, Portland Leather Goods reportedly shifted away from an institutional investor...
1d ago
FLEXP
Counter-Drone Deployment Showcases D-Fend Solutions at Major Ontario Music Festival

Counter-Drone Deployment Showcases D-Fend Solutions at Major Ontario Music Festival

A LinkedIn post from D-Fend Solutions describes its counter-drone technology being used to help secure what is characterized...
1d ago
DFEND
1Password Positions Identity Platform for Emerging AI Agent Security Needs

1Password Positions Identity Platform for Emerging AI Agent Security Needs

According to a recent LinkedIn post from 1Password, the company is outlining its perspective on how identity and...
1d ago
1PASS